ScoreWhy is Zhejiang Haisen Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.10% and Operating profit at 16.19% over the last 5 years
2
Flat results in Mar 26
- INTEREST COVERAGE RATIO(Q) Lowest at 41,761.61
- NET SALES(Q) Lowest at CNY 107.19 MM
- OPERATING PROFIT(Q) Lowest at CNY 32.03 MM
3
With ROE of 8.66%, it has a very attractive valuation with a 0.48 Price to Book Value
- Over the past year, while the stock has generated a return of -12.89%, its profits have risen by 9.7%
- At the current price, the company has a high dividend yield of 0.3
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -12.89% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Haisen Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Haisen Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Zhejiang Haisen Pharmaceutical Co., Ltd.
-100.0%
0.64
34.09%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.10%
EBIT Growth (5y)
16.19%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.34
Tax Ratio
13.11%
Dividend Payout Ratio
12.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.73%
ROE (avg)
8.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
1.83
EV to EBIT
12.12
EV to EBITDA
10.70
EV to Capital Employed
3.77
EV to Sales
3.32
PEG Ratio
NA
Dividend Yield
0.07%
ROCE (Latest)
31.09%
ROE (Latest)
8.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 178.59 MM
RAW MATERIAL COST(Y)
Fallen by 0.05% (YoY
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Zhejiang Haisen Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 178.59 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by 0.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
